| Gene symbol | CD22 | Synonyms | SIGLEC-2, SIGLEC2 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD22 molecule | ||||
| GTO ID | GTC1989 |
| Trial ID | NCT03692767 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD22 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD22 CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma |
| Year | 2018 |
| Country | China |
| Company sponsor | Allife Medical Science and Technology Co., Ltd. |
| Cohort 1 | |||||||||||
|
|||||||||||